Company Encyclopedia
View More
name
Aditxt
ADTX.US
Aditxt, Inc., a commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women’s health, and neurologic health. The company develops AditxtScore that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc.
1.890 T
ADTX.USMarket value -Rank by Market Cap -/-

Financial Score

17/12/2025 Update
D
BiotechnologyIndustry
Industry Ranking341/394
Industry medianC
Industry averageD
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE2796.29%A
    • Profit Margin-710498.74%E
    • Gross Margin2.14%E
  • Growth ScoreE
    • Revenue YoY-97.20%E
    • Net Profit YoY8.67%C
    • Total Assets YoY-60.46%E
    • Net Assets YoY-299.12%E
  • Cash ScoreE
    • Cash Flow Margin-0.01%D
    • OCF YoY-97.20%E
  • Operating ScoreE
    • Turnover0E
  • Debt ScoreE
    • Gearing Ratio175.08%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Why Aditxt Shares Are Trading Higher By Around 63%; Here Are 20 Stocks Moving Premarket

    Aditxt Inc (NASDAQ:ADTX) shares surged 63.4% in pre-market trading after filing a definitive proxy statement for a special stockholder meeting on Jan. 30, 2026, to vote on Nasdaq Marketplace Rule 5635(d) compliance. Other notable pre-market movers include Agape ATP Corp, Direct Digital Holdings, and DBV Technologies, with significant gains, while Children's Place Inc and others saw declines.

    benzinga_article·
    US
    ADTX
    +19.30%
    benzinga_article·
    US
    ADTX
    +19.30%

    What Sparked Aditxt (ADTX) Stock's 52% After‑Hours Surge?

    Aditxt Inc. (ADTX) shares surged 52.11% in after-hours trading to $2.16 following the filing of a definitive proxy statement for a special stockholder virtual meeting on Jan. 30, 2026. The proxy statement includes proposals for stock issuances, equity incentive expansion, a reverse stock split, and a strategic name change to bitXbio, Inc. ADTX has fallen 99.97% year to date and has a market capitalization of $794,410.

    fidelity·
    US
    ADTX
    +19.30%
    fidelity·
    US
    ADTX
    +19.30%

    Aditxt shares are trading lower after the company announced a $20 million offering.

    benzinga_article·
    US
    ADTX
    +19.30%
    benzinga_article·
    US
    ADTX
    +19.30%

    U.S. Stock Market Midday Update: Aditxt's stock price soared 12.16%, trading volume surged, and market volatility has drawn attention

    Aditxt rose 12.16%; AbbVie fell 1.67%, with a trading volume of USD 435 million; Precision BioSciences rose 0.41%, with a trading volume of USD 408 million; Amgen rose 0.98%, with a trading volume of USD 282 million; Gilead Sciences rose 0.66%, with a market capitalization of USD 158.8 billion

    Tracking Unusual Activity·
    US
    ADTX
    +19.30%
    Tracking Unusual Activity·
    US
    ADTX
    +19.30%

    Aditxt, Inc. Announces Strategic Transition to bitXbio

    Aditxt, Inc. announced its strategic transition to bitXbio, Inc. on November 18, 2025. The transition includes a name change, an Employee Stock Purchase Plan, and a strategy integrating blockchain and digital assets for health innovation. Additionally, Pearsanta plans an IPO for cancer detection technologies, and Evofem aims to regain a national listing and secure growth capital.

    TradingView·
    US
    ADTX
    +19.30%
    TradingView·
    US
    ADTX
    +19.30%
    © 2025 Longbridge｜Disclaimer